•
Jun 30, 2022
Guardant Health Q2 2022 Earnings Report
Reported a revenue increase of 19% year-over-year, driven by growth in clinical and biopharma testing volumes.
Key Takeaways
Guardant Health reported strong Q2 2022 financial results, with revenue reaching $109.1 million, a 19% increase compared to the previous year. The company saw significant growth in clinical and biopharma testing volumes, and received Medicare coverage for Guardant Reveal™.
Revenue of $109.1 million, up 19% year-over-year.
Clinical tests volume increased by 40% year-over-year.
Biopharmaceutical tests volume increased by 65% year-over-year.
Received Medicare coverage for Guardant Reveal™.
Guardant Health
Guardant Health
Guardant Health Revenue by Segment
Forward Guidance
Guardant Health continues to expect full year 2022 revenue to be in the range of $460 million to $470 million, representing 23% to 26% growth over full year 2021.